Treatment of acute hepatitis C in HIV infectionVOGEL, Martin; ROCKSTROH, Jürgen K.Journal of antimicrobial chemotherapy (Print). 2010, Vol 65, Num 1, pp 4-9, issn 0305-7453, 6 p.Article

Management of late-presenting patients with HIV infectionROCKSTROH, Jürgen K; GATELL, Jose; LANDMAN, Roland et al.Antiviral therapy (London). 2010, Vol 15, pp 25-30, issn 1359-6535, 6 p., SUP1Article

Natural History and Management of Hepatitis C: Does Sex Play a Role?BADEN, Rachel; ROCKSTROH, Jürgen K; BUTI, Maria et al.The Journal of infectious diseases. 2014, Vol 209, issn 0022-1899, S81-S85, SUP3Article

Liver histopathology in human immunodeficiency virus-hepatitis C virus co-infected patients with fatal liver diseaseLICHTERFELD, Mathias; HAAS, Susanne; FISCHER, Hans-Peter et al.Journal of gastroenterology and hepatology. 2005, Vol 20, Num 5, pp 739-745, issn 0815-9319, 7 p.Article

Evidence for Extensive Genotypic Diversity and Recombination of GB Virus C (GBV-C) in GermanyNEIBECKER, Markus; SCHWARZE-ZANDER, Carolynne; ROCKSTROH, Jürgen K et al.Journal of medical virology. 2011, Vol 83, Num 4, pp 685-694, issn 0146-6615, 10 p.Article

Late presentation of HIV treatment in EuropeANTINORI, Andrea; JOHNSON, Margaret; MORENO, Santiago et al.Antiviral therapy (London). 2010, Vol 15, issn 1359-6535, 36 p., SUP1Serial Issue

Raltegravir with Optimized Background Therapy for Resistant HIV-1 InfectionSTEIGBIGEL, Roy T; COOPER, David A; KATLAMA, Christine et al.The New England journal of medicine. 2008, Vol 359, Num 4, pp 339-354, issn 0028-4793, 16 p.Article

Efficacy and safety of raltegravir for treatment of HIV for 5 years in the BENCHMRK studies: final results of two randomised, placebo-controlled trialsERON, Joseph J; COOPER, David A; LOUTFY, Mona R et al.Lancet. Infectious diseases (print). 2013, Vol 13, Num 7, pp 587-596, issn 1473-3099, 10 p.Article

Selective escape from CD8⁺ T-cell responses represents a major driving force of human immunodeficiency virus type 1 (HIV-1) sequence diversity and reveals constraints on HIV-1 evolutionALLEN, Todd M; ALTFELD, Marcus; KAUFMANN, Daniel E et al.Journal of virology. 2005, Vol 79, Num 21, pp 13239-13249, issn 0022-538X, 11 p.Article

Report of a European Working Group on late presentation with HIV infection: recommendations and regional variationANTINORI, Andrea; JOHNSON, Margaret; MORENO, Santiago et al.Antiviral therapy (London). 2010, Vol 15, pp 31-35, issn 1359-6535, 5 p., SUP1Article

Subgroup and Resistance Analyses of Raltegravir for Resistant HIV-1 InfectionCOOPER, David A; STEIGBIGEL, Roy T; SCHECHTER, Mauro et al.The New England journal of medicine. 2008, Vol 359, Num 4, pp 355-365, issn 0028-4793, 11 p.Article

Comparison of GB virus C, HIV, and HCV infection markers in hemophiliacs exposed to non-inactivated or inactivated factor concentratesKUPFER, Bernd; RUF, Torsten; MATZ, Bertfried et al.Journal of clinical virology. 2005, Vol 34, Num 1, pp 42-47, issn 1386-6532, 6 p.Article

HIV-related stigma within communities of gay men: A literature reviewSMIT, Peter J; BRADY, Michael; THOMPSON, Marc et al.AIDS Care (Print). 2012, Vol 24, Num 3-4, pp 405-412, issn 0954-0121, 8 p.Article

Long-Term Efficacy and Safety of Raltegravir Combined with Optimized Background Therapy in Treatment- Experienced Patients with Drug- Resistant HIV Infection: Week 96 Results of the BENCHMRK 1 and 2 Phase III TrialsSTEIGBIGEL, Roy T; COOPER, David A; YENI, Patrick et al.Clinical infectious diseases. 2010, Vol 50, Num 4, pp 605-612, issn 1058-4838, 8 p.Article

Compensatory mutations at the HIV cleavage sites p7/pl and p1/p6-gag in therapy-naive and therapy-experienced patientsVERHEYEN, Jens; LITAU, Elena; PFISTER, Herbert et al.Antiviral therapy (London). 2006, Vol 11, Num 7, pp 879-887, issn 1359-6535, 9 p.Article

Frequent detection of cell-associated HIV-1 RNA in patients with plasma viral load <50 copies/mlKUPFER, Bernd; MATZ, Bertfried; DÄUMER, Martin P et al.Journal of medical virology. 2007, Vol 79, Num 10, pp 1440-1445, issn 0146-6615, 6 p.Article

Medical and societal consequences of late presentationMORENO, Santiago; MOCROFT, Amanda; D'ARMINIO MONFORTE, Antonella et al.Antiviral therapy (London). 2010, Vol 15, pp 9-15, issn 1359-6535, 7 p., SUP1Article

Phospholipid autoantibodies and the antiphospholipid antibody syndrome: Diagnostic accuracy of 23 methods studied by variation in ROC curves with number of clinical manifestationsWASMUTH, Jan-Christian; MINARRO, Desamparados Oliver Y; HOMRIGHAUSEN, Angela et al.Clinical chemistry (Baltimore, Md.). 2002, Vol 48, Num 7, pp 1004-1010, issn 0009-9147Article

Painful multifocal arthritis : Therapy with rhenium 186 hydroxyethylidenediphosphonate (¹⁸⁶Re HEDP) after failed treatment with medication-initial results of a prospective studyPALMEDO, Holger; ROCKSTROH, Jürgen K; BANGARD, Michael et al.Radiology. 2001, Vol 221, Num 1, pp 256-260, issn 0033-8419Article

Bacteremia Caused by a Novel Helicobacter Species in a 28-Year-Old Man with X-Linked AgammaglobulinemiaSCHWARZE-ZANDER, Carolynne; BECKER, Sabine; WENZEL, Jörg et al.Journal of clinical microbiology (Print). 2010, Vol 48, Num 12, pp 4672-4676, issn 0095-1137, 5 p.Article

Reduced CC chemokine receptor (CCR) 1 and CCR5 surface expression on peripheral blood T lymphocytes from patients with chronic hepatitis C infectionLICHTERFELD, Mathias; LEIFELD, Ludger; NISCHALKE, Hans Dieter et al.The Journal of infectious diseases. 2002, Vol 185, Num 12, pp 1803-1807, issn 0022-1899Article

Earlier testing for HIV ― how do we prevent late presentation?YAZDANPANAH, Yazdan; LANGE, Joep; GERSTOFT, Jan et al.Antiviral therapy (London). 2010, Vol 15, pp 17-24, issn 1359-6535, 8 p., SUP1Article

Hepatitis C coinfection enhances sensitization of CD4⁺ T-cells towards Fas-induced apoptosis in viraemic and HAART-controlled HIV-1-positive patientsKÖRNER, Christian; TOLKSDORF, Felix; RIESNER, Katarina et al.Antiviral therapy (London). 2011, Vol 16, Num 7, pp 1047-1055, issn 1359-6535, 9 p.Article

Rapid determination of the Δ32 deletion in the human CC-chemokine receptor 5 (CCR5) gene without DNA extraction by LightCycler real-time polymerase chain reactionNISCHALKE, Hans Dieter; NATTERMANN, Jacob; LICHTERFELD, Mathias et al.AIDS research and human retroviruses. 2004, Vol 20, Num 7, pp 750-754, issn 0889-2229, 5 p.Article

Lopinavir/ritonavir plus saquinavir in salvage therapy; pharmacokinetics, tolerability and efficacyLA PORTE, Charles J. L; WASMUTH, Jan-Christian; SCHNEIDER, Katrin et al.AIDS (London). 2003, Vol 17, Num 11, pp 1700-1702, issn 0269-9370, 3 p.Article